Squarepoint’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$930K Sell
18,277
-16,185
-47% -$824K ﹤0.01% 1569
2025
Q1
$1.55M Buy
34,462
+12,780
+59% +$576K ﹤0.01% 1289
2024
Q4
$897K Buy
+21,682
New +$897K ﹤0.01% 1592
2024
Q3
Sell
-67,421
Closed -$2.31M 2837
2024
Q2
$2.31M Buy
67,421
+26,154
+63% +$894K ﹤0.01% 1009
2024
Q1
$1.04M Sell
41,267
-90,945
-69% -$2.28M ﹤0.01% 1340
2023
Q4
$3.9M Buy
132,212
+32,555
+33% +$961K 0.01% 759
2023
Q3
$3.15M Buy
99,657
+62,398
+167% +$1.97M 0.01% 782
2023
Q2
$964K Buy
+37,259
New +$964K ﹤0.01% 1272
2023
Q1
Sell
-15,117
Closed -$295K 2567
2022
Q4
$295K Buy
+15,117
New +$295K ﹤0.01% 1712
2021
Q1
Sell
-21,441
Closed -$374K 2859
2020
Q4
$374K Sell
21,441
-2,220
-9% -$38.7K ﹤0.01% 1710
2020
Q3
$456K Sell
23,661
-4,326
-15% -$83.4K 0.01% 1413
2020
Q2
$545K Sell
27,987
-6,879
-20% -$134K 0.01% 1259
2020
Q1
$488K Buy
+34,866
New +$488K 0.01% 1053